XML 31 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Apr. 12, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-36912    
Entity Registrant Name CIDARA THERAPEUTICS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-1537286    
Entity Address, Address Line One 6310 Nancy Ridge Drive,    
Entity Address, Address Line Two Suite 101    
Entity Address, City or Town San Diego,    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92121    
City Area Code (858)    
Local Phone Number 752-6170    
Title of 12(b) Security Common Stock, $0.0001 Par Value    
Trading Symbol “CDTX”    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction true    
Document Financial Statement Restatement Recovery Analysis false    
Entity Shell Company false    
Entity Public Float     $ 100.2
Entity Common Stock, Shares Outstanding   91,235,020  
Amendment Flag false    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001610618